SEC22A Activators
SEC22A Activators are a class of chemical compounds specifically designed to target and enhance the activity of SEC22A, a protein that plays a pivotal role in the vesicle trafficking system of cells, particularly within the endoplasmic reticulum (ER) to Golgi apparatus transport pathway. SEC22A belongs to the SNARE (Soluble NSF Attachment Protein Receptor) family, a group of proteins crucial for the fusion of vesicles with their target membranes, facilitating the transport of proteins and lipids between cellular compartments. The activation of SEC22A could potentially optimize vesicular transport efficiency, impacting processes such as protein sorting, secretion, and membrane biogenesis. The development of SEC22A Activators involves sophisticated chemical synthesis aimed at producing molecules that can specifically interact with SEC22A, possibly inducing conformational changes that enhance its SNARE complex formation ability or its interaction with other proteins involved in vesicle trafficking. These activators are characterized by their selectivity for SEC22A and their ability to modulate its function, requiring a deep understanding of the protein's structure, including its SNARE motifs and the regions critical for its function in vesicle trafficking.
The investigation of SEC22A Activators incorporates a multidisciplinary approach, combining elements of cell biology, biochemistry, and structural biology to understand the interaction between these activators and SEC22A. Researchers utilize a variety of techniques such as co-immunoprecipitation and pull-down assays to study the protein-protein interactions involving SEC22A and to assess how activators influence these interactions. Functional assays, including vesicle trafficking and fusion assays, are crucial for evaluating the effects of activators on SEC22A-mediated transport processes. Structural studies, such as X-ray crystallography or cryo-electron microscopy, provide insights into the three-dimensional structure of SEC22A, identifying potential activator binding sites and elucidating the mechanism by which activators enhance SEC22A activity. Computational modeling and molecular docking further aid in predicting the interactions between SEC22A and potential activators, guiding the rational design and optimization of these molecules for increased efficacy and specificity. Through this comprehensive research effort, the study of SEC22A Activators aims to elucidate the regulatory mechanisms of vesicle trafficking and the role of SEC22A in this essential cellular process, contributing to our broader understanding of cellular transport systems and protein regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which could lead to the activation of CREB and subsequent upregulation of various genes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences glycogen synthase kinase 3 (GSK-3) activity, which might affect gene expression through Wnt signaling and other GSK-3 related transcription factors. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As an active metabolite of vitamin A, retinoic acid can regulate gene expression by activating its nuclear receptors, potentially influencing numerous genes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can activate glucocorticoid receptors, leading to translocation into the nucleus and binding to glucocorticoid response elements in gene promoters. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can modulate transcription factors and alter gene expression profiles. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor that may increase histone acetylation, potentially leading to a relaxed chromatin structure and activation of gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This form of estrogen can bind to estrogen receptors, which may affect gene transcription through interaction with estrogen-responsive elements in the DNA. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
As a glucocorticoid receptor antagonist, mifepristone may alter the expression of genes regulated by glucocorticoids. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90, potentially disrupting its chaperone function for various client proteins and altering subsequent signaling pathways and gene expression. | ||||||
3,3′-Diindolylmethane | 1968-05-4 | sc-204624 sc-204624A sc-204624B sc-204624C sc-204624D sc-204624E | 100 mg 500 mg 5 g 10 g 50 g 1 g | $37.00 $65.00 $89.00 $421.00 $681.00 $66.00 | 8 | |
By modulating the AhR (aryl hydrocarbon receptor), DIM may influence the expression of genes involved in xenobiotic metabolism. | ||||||